lupanine has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Düfer, M; García-López, PM; Gurrola-Díaz, CM; Vargas-Guerrero, B; Wiedemann, M; Wink, M | 1 |
| Abramczyk, M; Bobkiewicz-Kozłowska, T; Dworacka, M; Garcia Lopez, PM; Kolanoś, R; Kuczyński, S; Winiarska, H; Wysocka, W | 1 |
2 other study(ies) available for lupanine and Alloxan Diabetes
| Article | Year |
|---|---|
Lupanine Improves Glucose Homeostasis by Influencing KATP Channels and Insulin Gene Expression.
Topics: Animals; Arginine; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation; Homeostasis; Insulin; Insulin Secretion; Insulin-Secreting Cells; KATP Channels; Mice; Mice, Inbred C57BL; Rats; Sparteine; Streptozocin | 2015 |
Hypoglycaemic effect of quinolizidine alkaloids--lupanine and 2-thionosparteine on non-diabetic and streptozotocin-induced diabetic rats.
Topics: Alkaloids; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin; Male; Rats; Rats, Wistar; Sparteine; Streptozocin | 2007 |